Credit Agricole S A Abb Vie Inc. Put Options Transaction History

Credit Agricole S A

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $5.59 Million - $6.37 Million	-35,000 Reduced 41.18%	50,000 $9.11 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $6.88 Million - $7.75 Million	50,000 Added 142.86%	85,000 $13.2 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.45 Million - $1.67 Million	-10,000 Reduced 22.22%	35,000 $5.58 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $1.34 Million - $1.54 Million	10,000 Added 28.57%	45,000 $6.04 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $3.72 Million - $4.23 Million	35,000 New	35,000 $3.78 Million

3,817

1.25B

13M

10M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.